SCHEMBL3755933

SCHEMBL3755933

CCCCCC(NC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)NC(=O)/C(C)=C/c1c(C)c(OC)c(OC)c(OC)c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 5/20 0.47
▸ HLCS P50747 2/20 0.46
▸ CNR1 P21554 3/20 0.45
▸ MEN1 O00255 1/20 0.42
▸ ABL1 P00519 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ IDE P14735 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ RIN1 Q13671 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ CNR2 P34972 2/20 0.41
▸ CA12 O43570 3/20 0.41
▸ CA1 P00915 3/20 0.41
▸ CA2 P00918 3/20 0.41
▸ CA9 Q16790 3/20 0.41
▸ F2 P00734 1/20 0.39
▸ PRSS1 P07477 1/20 0.39
▸ PRSS2 P07478 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3755935 0.82 TDP1 (0.56) TDP1CNR1CNR2CA12CA1
SCHEMBL3755939 0.82 TDP1 (0.56) TDP1CNR1CNR2CA12CA1
SCHEMBL13049573 0.80 TDP1 (0.53) TDP1HLCSCNR1CNR2CA12
SCHEMBL16938350 0.80 TDP1 (0.53) TDP1HLCSCNR1CNR2CA12
SCHEMBL19462683 0.75 HLCS (0.65) TDP1HLCSCNR1MEN1ABL1
SCHEMBL4418125 0.75 TDP1 (0.57) TDP1HLCSCNR1MEN1ABL1
Hydrochloric Acid SCHEMBL7376022 0.74 HLCS (0.63) TDP1HLCSCNR1MEN1ABL1
SCHEMBL15185874 0.73 HLCS (0.67) TDP1HLCSCNR1MEN1ABL1
SCHEMBL7903793 0.73 HLCS (0.63) TDP1HLCSCNR1MEN1ABL1
SCHEMBL5817718 0.73 HLCS (0.63) TDP1HLCSCNR1MEN1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203161-B1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF UNIV INDIANA RES & TECH CORP (US) 2018-05-09 — — EP disclosed
US-9089605-B2 Quinone derivatives, pharmaceutical compositions, and uses thereof INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-07-28 — — US disclosed
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF PURDUE RESEARCH FOUNDATION 2010-11-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF APEX1, NQO1, REV1 TDP1 118/4885HLCS 1545/4885CNR1 4285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback